துறை ஆஃப் மருந்து பள்ளி மருத்துவ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection
SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists.
Given that both vaccines and therapeutics are aimed at the spike protein, which we saw mutate in our patient, our study raises the worrying possibility that the virus could mutate to outwit our vaccines
Ravi Gupta
Writing in
Nature, a team led by Cambridge researchers report how they were able to observe SARS-CoV-2 mutating in the case of an immunocompromised patient treated with convalescent plasma. In particular, they saw the emergence of a key mutation also seen in the new variant that led to the UK being forced once again into strict lockdown, though there is no suggestion that the variant originated from this patient. ....

United Kingdom , Ravi Gupta , National Institute Of Health Research , Cambridge Institute Of Therapeutic Immunology Infectious Disease , Genomics United Kingdom Consortium , Melinda Gates Foundation , Cambridge University Hospitals , Research Council , Cambridge Institute , Therapeutic Immunology , Infectious Disease , Medical Research Council , National Institute , Health Research , Melinda Gates , National Institute For Health Research Nihr , Bill And Melinda Gates Foundation , Wellcome Ravindra Gupta Coronavirus , Covid 19 , Infectious Diseases Covid 19 , Corona Virus , Infectious Diseases Cambridge Fights Covid , Cambridge Infectious Diseases , Cambridge Institute Of Therapeutic Immunology And Infectious Disease Citiid , Covid 19 Genomics Uk Cog Consortium , School Of Clinical Medicine ,